IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Aakaar Medical Technologies Ltd.
Issue Open Date 20-Jun-25  
Issue Closing Date 24-Jun-25  
Application Money 100  
Allotment Money  
Price Band 68 - 72  
Minimium Application No. 1600  
Issue Size (Shares) 2683200  
Market Lot 1.00  
Objective
1. Funding working capital requirements of our Company;2. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     982400   NA  
Qualified Institutional Buyers     2496000   NA  
Retail Individual Investors     2411200   NA  
Business Description
“Aakaar Medical Technologies Private Limited” was incorporated in the year 2013 under the leadership of Mr. Dilip Meswani who has been in the Aesthetic business since more than 25 years. He commenced his journey in the aesthetics business in 1999 through a pro
more...
Promoter's Holding
Total Share Capital   9496513  
Offered to Public   3750400  
Promoter's Holding (Pre-Issue)   91.11  
Promoter's Holding (Post-Issue)   67.05  
Address
801
Heritage Plaza
Teli Galli Cross Road
Andheri (East)
Mumbai ,
Maharashtra ,
400069
Phone: 8452844024
Email: companysecretary@aakaarmedical.in
Website: www.aakaarmedical.in
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
NSE
Lead Manager
Indorient Financial Services Ltd.
Promoters
Bindi Dilip Meswani
Dilip Ramesh Meswani
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.